Rational design of potent GSK3beta inhibitors with selectivity for Cdk1 and Cdk2.
Lesuisse, D., Dutruc-Rosset, G., Tiraboschi, G., Dreyer, M.K., Maignan, S., Chevalier, A., Halley, F., Bertrand, P., Burgevin, M.C., Quarteronet, D., Rooney, T.(2010) Bioorg Med Chem Lett 20: 1985-1989
- PubMed: 20167481 
- DOI: https://doi.org/10.1016/j.bmcl.2010.01.114
- Primary Citation of Related Structures:  
3LAU, 3LFN, 3LFQ, 3LFS - PubMed Abstract: 
From an HTS hit, a series of potent and selective inhibitors of GSK3beta have been designed based on a Cdk2-homology model and with the help of several crystal structures of the compounds within Cdk2.
Organizational Affiliation: 
Medicinal Chemistry, 13 Quai Jules Guesde, 94300 Vitry-sur-Seine, France. dominique.lesuisse@sanofi-aventis.com